QA: Akorn INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2015_Akorn_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000003116, Akorn INC

  xvar xval
0 AssetsCurrent 494,329,000
1 IntangibleAssetsNetIncludingGoodwill 982,992,000
2 PropertyPlantAndEquipmentNet 143,788,000
3 remainder_Assets 285,792,000
4 LiabilitiesCurrent 134,165,000
5 LiabilitiesNoncurrent 1,385,985,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,042,531,784
8 SellingGeneralAndAdministrativeExpense 152,676,560
9 ResearchAndDevelopmentExpense 43,076,326
10 remainder_Expenses 100,052,169
11 remainder_Revenues 1,963,415,046
12 remainder_NetIncome -19,798,546
13 remainder_ComprehensiveNetIncome -2,692,001
  yvar yval
0 Assets 1,906,901,000
1 Liabilities 1,520,150,000
2 Expenses 1,338,336,839
3 Revenues 1,963,415,046
4 StockholdersEquity 386,751,000
5 NetIncome 605,279,661
6 ComprehensiveNetIncome 603,933,660
7 BaseVar 3,375,646,716
8 EconomicCapitalRatiobeforeLimitedLiability 0.844
9 EconomicCapitalRatio 2.18

Edgar->Model Mapping

Feature Distribution

Change over Time